@article {1528399,
	title = {Potential small-molecule drugs as available weapons to fight novel coronavirus (2019-nCoV): A review},
	journal = {Cell Biochem Funct},
	volume = {39},
	number = {1},
	year = {2021},
	month = {2021 Jan},
	pages = {4-9},
	abstract = {Since the new coronavirus known as 2019-nCoV (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has widely spread in Wuhan, China, with severe pneumonia, scientists and physicians have made remarkable efforts to use various options such as monoclonal antibodies, peptides, vaccines, small-molecule drugs and interferon therapies to control, prevent or treatment infections of 2019-nCoV. However, no vaccine or drug has yet been confirmed to completely treat 2019-nCoV. In this review, we focus on the use of potential available small-molecule drug candidates for treating infections caused by 2019-nCoV.},
	keywords = {Antiviral Agents, China, COVID-19, Humans, SARS-CoV-2},
	issn = {1099-0844},
	doi = {10.1002/cbf.3576},
	author = {Rahimkhoei, Vahid and Jabbari, Nassrollah and Nourani, Aynaz and Sharifi, Sina and Akbari, Ali}
}
